D
Hemostemix Inc.
HEM.V
TSX
D
Sell
12/31/2024Upgraded
Hemostemix Inc. (HEM.V) was upgraded to D- from E+ on 12/31/2024 due to an increase in the volatility index.
Hemostemix Inc. (HEM.V) was upgraded to D- from E+ on 12/31/2024 due to an increase in the volatility index.
E
Sell
11/27/2024Downgrade
Hemostemix Inc. (HEM.V) was downgraded to E+ from D- on 11/27/2024 due to a decline in the volatility index.
Hemostemix Inc. (HEM.V) was downgraded to E+ from D- on 11/27/2024 due to a decline in the volatility index.
D
Sell
10/28/2024Upgraded
Hemostemix Inc. (HEM.V) was upgraded to D- from E+ on 10/28/2024 due to an increase in the volatility index and total return index.
Hemostemix Inc. (HEM.V) was upgraded to D- from E+ on 10/28/2024 due to an increase in the volatility index and total return index.
E
Sell
10/11/2024Downgrade
Hemostemix Inc. (HEM.V) was downgraded to E+ from D- on 10/11/2024 due to a decline in the volatility index.
Hemostemix Inc. (HEM.V) was downgraded to E+ from D- on 10/11/2024 due to a decline in the volatility index.
D
Sell
9/26/2024Upgraded
Hemostemix Inc. (HEM.V) was upgraded to D- from E+ on 9/26/2024 due to an increase in the volatility index and total return index.
Hemostemix Inc. (HEM.V) was upgraded to D- from E+ on 9/26/2024 due to an increase in the volatility index and total return index.
E
Sell
11/24/2023Downgrade
Hemostemix Inc. (HEM.V) was downgraded to E+ from D- on 11/24/2023 due to a decline in the total return index and volatility index.
Hemostemix Inc. (HEM.V) was downgraded to E+ from D- on 11/24/2023 due to a decline in the total return index and volatility index.
D
Sell
11/8/2023Upgraded
Hemostemix Inc. (HEM.V) was upgraded to D- from E+ on 11/8/2023 due to a noticeable increase in the growth index and volatility index. Earnings per share increased from -$0.0124 to -$0.0026, EBIT increased 64.43% from -$812.4 to -$289, and operating cash flow increased 43.13% from -$525.9 to -$299.1.
Hemostemix Inc. (HEM.V) was upgraded to D- from E+ on 11/8/2023 due to a noticeable increase in the growth index and volatility index. Earnings per share increased from -$0.0124 to -$0.0026, EBIT increased 64.43% from -$812.4 to -$289, and operating cash flow increased 43.13% from -$525.9 to -$299.1.
E
Sell
8/30/2023Downgrade
Hemostemix Inc. (HEM.V) was downgraded to E+ from D- on 8/30/2023 due to a decline in the volatility index and total return index.
Hemostemix Inc. (HEM.V) was downgraded to E+ from D- on 8/30/2023 due to a decline in the volatility index and total return index.
D
Sell
8/7/2023Upgraded
Hemostemix Inc. (HEM.V) was upgraded to D- from E+ on 8/7/2023 due to an increase in the volatility index, growth index and total return index.
Hemostemix Inc. (HEM.V) was upgraded to D- from E+ on 8/7/2023 due to an increase in the volatility index, growth index and total return index.
E
Sell
7/21/2023Downgrade
Hemostemix Inc. (HEM.V) was downgraded to E+ from D- on 7/21/2023 due to a large decline in the total return index, growth index and volatility index. EBIT declined 80.69% from -$449.6 to -$812.4, and earnings per share declined from -$0.0109 to -$0.0124.
Hemostemix Inc. (HEM.V) was downgraded to E+ from D- on 7/21/2023 due to a large decline in the total return index, growth index and volatility index. EBIT declined 80.69% from -$449.6 to -$812.4, and earnings per share declined from -$0.0109 to -$0.0124.
D
Sell
3/14/2023Downgrade
Hemostemix Inc. (HEM.V) was downgraded to D- from D on 03/14/2023.
Hemostemix Inc. (HEM.V) was downgraded to D- from D on 03/14/2023.
D
Sell
2/23/2023Upgraded
Hemostemix Inc. (HEM.V) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index and volatility index.
Hemostemix Inc. (HEM.V) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index and volatility index.
D
Sell
2/8/2023Downgrade
Hemostemix Inc. (HEM.V) was downgraded to D- from D on 02/08/2023.
Hemostemix Inc. (HEM.V) was downgraded to D- from D on 02/08/2023.
D
Sell
5/16/2022Upgraded
Hemostemix Inc. (HEM.V) was upgraded to D from E+ on 5/16/2022 due to an increase in the total return index and volatility index.
Hemostemix Inc. (HEM.V) was upgraded to D from E+ on 5/16/2022 due to an increase in the total return index and volatility index.
E
Sell
5/13/2022Downgrade
Hemostemix Inc. (HEM.V) was downgraded to E+ from D on 05/13/2022.
Hemostemix Inc. (HEM.V) was downgraded to E+ from D on 05/13/2022.
D
Sell
5/4/2022Upgraded
Hemostemix Inc. (HEM.V) was upgraded to D from E+ on 05/04/2022.
Hemostemix Inc. (HEM.V) was upgraded to D from E+ on 05/04/2022.
E
Sell
5/3/2022Downgrade
Hemostemix Inc. (HEM.V) was downgraded to E+ from D- on 5/3/2022 due to a noticeable decline in the valuation index, solvency index and growth index. EBIT declined 479.16% from -$608.4 to -$3.52M, operating cash flow declined 130.52% from -$670.4 to -$1.55M, and debt to equity increased from -0.6 to -0.28.
Hemostemix Inc. (HEM.V) was downgraded to E+ from D- on 5/3/2022 due to a noticeable decline in the valuation index, solvency index and growth index. EBIT declined 479.16% from -$608.4 to -$3.52M, operating cash flow declined 130.52% from -$670.4 to -$1.55M, and debt to equity increased from -0.6 to -0.28.
D
Sell
4/20/2022Downgrade
Hemostemix Inc. (HEM.V) was downgraded to D- from D on 4/20/2022 due to a decline in the valuation index.
Hemostemix Inc. (HEM.V) was downgraded to D- from D on 4/20/2022 due to a decline in the valuation index.
D
Sell
3/4/2022Upgraded
Hemostemix Inc. (HEM.V) was upgraded to D from D- on 3/4/2022 due to an increase in the total return index and volatility index.
Hemostemix Inc. (HEM.V) was upgraded to D from D- on 3/4/2022 due to an increase in the total return index and volatility index.
D
Sell
2/17/2022Downgrade
Hemostemix Inc. (HEM.V) was downgraded to D- from D on 2/17/2022 due to a decline in the volatility index.
Hemostemix Inc. (HEM.V) was downgraded to D- from D on 2/17/2022 due to a decline in the volatility index.
D
Sell
1/31/2022Upgraded
Hemostemix Inc. (HEM.V) was upgraded to D from D- on 1/31/2022 due to an increase in the volatility index.
Hemostemix Inc. (HEM.V) was upgraded to D from D- on 1/31/2022 due to an increase in the volatility index.
D
Sell
12/15/2021Downgrade
Hemostemix Inc. (HEM.V) was downgraded to D- from D on 12/15/2021 due to a noticeable decline in the total return index.
Hemostemix Inc. (HEM.V) was downgraded to D- from D on 12/15/2021 due to a noticeable decline in the total return index.
D
Sell
11/9/2021Upgraded
Hemostemix Inc. (HEM.V) was upgraded to D from E+ on 11/09/2021.
Hemostemix Inc. (HEM.V) was upgraded to D from E+ on 11/09/2021.
E
Sell
11/8/2021Downgrade
Hemostemix Inc. (HEM.V) was downgraded to E+ from D on 11/8/2021 due to a large decline in the solvency index, growth index and volatility index. Operating cash flow declined 422.13% from $254.9 to -$821.1, earnings per share declined from -$0.0096 to -$0.019, and EBIT declined 21.38% from -$524.7 to -$636.9.
Hemostemix Inc. (HEM.V) was downgraded to E+ from D on 11/8/2021 due to a large decline in the solvency index, growth index and volatility index. Operating cash flow declined 422.13% from $254.9 to -$821.1, earnings per share declined from -$0.0096 to -$0.019, and EBIT declined 21.38% from -$524.7 to -$636.9.
D
Sell
1/13/2021Upgraded
Hemostemix Inc. (HEM.V) was upgraded to D from D- on 1/13/2021 due to a substantial increase in the growth index, total return index and volatility index. Operating cash flow increased 55.39% from -$864.8 to -$385.8, EBIT increased 26.17% from -$1.48M to -$1.09M, and earnings per share increased from -$0.0401 to -$0.0321.
Hemostemix Inc. (HEM.V) was upgraded to D from D- on 1/13/2021 due to a substantial increase in the growth index, total return index and volatility index. Operating cash flow increased 55.39% from -$864.8 to -$385.8, EBIT increased 26.17% from -$1.48M to -$1.09M, and earnings per share increased from -$0.0401 to -$0.0321.
D
Sell
12/4/2020Upgraded
Hemostemix Inc. (HEM.V) was upgraded to D- from E+ on 12/4/2020 due to an increase in the volatility index and total return index.
Hemostemix Inc. (HEM.V) was upgraded to D- from E+ on 12/4/2020 due to an increase in the volatility index and total return index.
E
Sell
9/4/2020Downgrade
Hemostemix Inc. (HEM.V) was downgraded to E+ from D- on 9/4/2020 due to a substantial decline in the growth index, volatility index and valuation index. EBIT declined 1,834.42% from -$76.4 to -$1.48M, earnings per share declined from -$0.0003 to -$0.0022, and operating cash flow declined 508.59% from -$142.1 to -$864.8.
Hemostemix Inc. (HEM.V) was downgraded to E+ from D- on 9/4/2020 due to a substantial decline in the growth index, volatility index and valuation index. EBIT declined 1,834.42% from -$76.4 to -$1.48M, earnings per share declined from -$0.0003 to -$0.0022, and operating cash flow declined 508.59% from -$142.1 to -$864.8.
D
Sell
9/1/2020Downgrade
Hemostemix Inc. (HEM.V) was downgraded to D- from D on 9/1/2020 due to a decline in the volatility index.
Hemostemix Inc. (HEM.V) was downgraded to D- from D on 9/1/2020 due to a decline in the volatility index.
D
Sell
8/17/2020Upgraded
Hemostemix Inc. (HEM.V) was upgraded to D from D- on 8/17/2020 due to an increase in the volatility index.
Hemostemix Inc. (HEM.V) was upgraded to D from D- on 8/17/2020 due to an increase in the volatility index.
D
Sell
7/31/2020Downgrade
Hemostemix Inc. (HEM.V) was downgraded to D- from D on 7/31/2020 due to a decline in the volatility index.
Hemostemix Inc. (HEM.V) was downgraded to D- from D on 7/31/2020 due to a decline in the volatility index.
D
Sell
7/15/2020Upgraded
Hemostemix Inc. (HEM.V) was upgraded to D from D- on 7/15/2020 due to a major increase in the growth index, solvency index and total return index. The quick ratio increased from 0.02 to 0.18, EBIT increased 81.79% from -$419.5 to -$76.4, and earnings per share increased from -$0.0015 to -$0.0003.
Hemostemix Inc. (HEM.V) was upgraded to D from D- on 7/15/2020 due to a major increase in the growth index, solvency index and total return index. The quick ratio increased from 0.02 to 0.18, EBIT increased 81.79% from -$419.5 to -$76.4, and earnings per share increased from -$0.0015 to -$0.0003.
D
Sell
5/18/2020Upgraded
Hemostemix Inc. (HEM.V) was upgraded to D- from E+ on 5/18/2020 due to an increase in the volatility index.
Hemostemix Inc. (HEM.V) was upgraded to D- from E+ on 5/18/2020 due to an increase in the volatility index.
E
Sell
5/1/2020Downgrade
Hemostemix Inc. (HEM.V) was downgraded to E+ from D- on 5/1/2020 due to a substantial decline in the solvency index, efficiency index and total return index.
Hemostemix Inc. (HEM.V) was downgraded to E+ from D- on 5/1/2020 due to a substantial decline in the solvency index, efficiency index and total return index.
D
Sell
11/29/2019Downgrade
Hemostemix Inc. (HEM.V) was downgraded to D- from D on 11/29/2019 due to a large decline in the solvency index, growth index and total return index. Operating cash flow declined 18.79% from -$820.8 to -$975, earnings per share declined from -$0.0033 to -$0.0034, and EBIT declined 0.46% from -$977.2 to -$981.7.
Hemostemix Inc. (HEM.V) was downgraded to D- from D on 11/29/2019 due to a large decline in the solvency index, growth index and total return index. Operating cash flow declined 18.79% from -$820.8 to -$975, earnings per share declined from -$0.0033 to -$0.0034, and EBIT declined 0.46% from -$977.2 to -$981.7.
D
Sell
5/30/2019Upgraded
Hemostemix Inc. (HEM.V) was upgraded to D from E+ on 5/30/2019 due to a large increase in the efficiency index, valuation index and growth index. Operating cash flow increased 26.52% from -$862.4 to -$633.7, EBIT increased 17.89% from -$1.41M to -$1.16M, and earnings per share increased from -$0.0044 to -$0.0039.
Hemostemix Inc. (HEM.V) was upgraded to D from E+ on 5/30/2019 due to a large increase in the efficiency index, valuation index and growth index. Operating cash flow increased 26.52% from -$862.4 to -$633.7, EBIT increased 17.89% from -$1.41M to -$1.16M, and earnings per share increased from -$0.0044 to -$0.0039.
E
Sell
2/15/2019Downgrade
Hemostemix Inc. (HEM.V) was downgraded to E+ from D- on 2/15/2019 due to a decline in the volatility index.
Hemostemix Inc. (HEM.V) was downgraded to E+ from D- on 2/15/2019 due to a decline in the volatility index.
D
Sell
11/26/2018Downgrade
Hemostemix Inc. (HEM.V) was downgraded to D- from D on 11/26/2018 due to a decline in the solvency index, valuation index and growth index. The quick ratio declined from 4.68 to 3.43, operating cash flow declined 25.14% from -$864.6 to -$1.08M, and earnings per share declined from -$0.0043 to -$0.0044.
Hemostemix Inc. (HEM.V) was downgraded to D- from D on 11/26/2018 due to a decline in the solvency index, valuation index and growth index. The quick ratio declined from 4.68 to 3.43, operating cash flow declined 25.14% from -$864.6 to -$1.08M, and earnings per share declined from -$0.0043 to -$0.0044.
D
Sell
10/19/2018Upgraded
Hemostemix Inc. (HEM.V) was upgraded to D from D- on 10/19/2018 due to an increase in the total return index and volatility index.
Hemostemix Inc. (HEM.V) was upgraded to D from D- on 10/19/2018 due to an increase in the total return index and volatility index.
D
Sell
8/24/2018Upgraded
Hemostemix Inc. (HEM.V) was upgraded to D- from E+ on 8/24/2018 due to an increase in the total return index, growth index and volatility index.
Hemostemix Inc. (HEM.V) was upgraded to D- from E+ on 8/24/2018 due to an increase in the total return index, growth index and volatility index.
E
Sell
12/1/2017Downgrade
Hemostemix Inc. (HEM.V) was downgraded to E+ from D- on 12/1/2017 due to a noticeable decline in the efficiency index, growth index and valuation index. Net income declined 418.86% from -$379.1 to -$1.97M, EBIT declined 380.55% from -$322.9 to -$1.55M, and earnings per share declined from -$0.0051 to -$0.016.
Hemostemix Inc. (HEM.V) was downgraded to E+ from D- on 12/1/2017 due to a noticeable decline in the efficiency index, growth index and valuation index. Net income declined 418.86% from -$379.1 to -$1.97M, EBIT declined 380.55% from -$322.9 to -$1.55M, and earnings per share declined from -$0.0051 to -$0.016.
D
Sell
6/6/2017Downgrade
Hemostemix Inc. (HEM.V) was downgraded to D- from D on 6/6/2017 due to a significant decline in the efficiency index, solvency index and growth index. Operating cash flow declined 44.71% from -$323.4 to -$468, debt to equity increased from -0.4 to -0.39, and EBIT declined 2.11% from -$322.4 to -$329.2.
Hemostemix Inc. (HEM.V) was downgraded to D- from D on 6/6/2017 due to a significant decline in the efficiency index, solvency index and growth index. Operating cash flow declined 44.71% from -$323.4 to -$468, debt to equity increased from -0.4 to -0.39, and EBIT declined 2.11% from -$322.4 to -$329.2.
D
Sell
5/31/2016Upgraded
Hemostemix Inc. (HEM.V) was upgraded to D from E+ on 5/31/2016 due to a significant increase in the efficiency index, growth index and valuation index. Earnings per share increased from -$0.0133 to -$0.0073, EBIT increased 44.29% from -$868 to -$483.6, and net income increased 42.53% from -$871.6 to -$500.9.
Hemostemix Inc. (HEM.V) was upgraded to D from E+ on 5/31/2016 due to a significant increase in the efficiency index, growth index and valuation index. Earnings per share increased from -$0.0133 to -$0.0073, EBIT increased 44.29% from -$868 to -$483.6, and net income increased 42.53% from -$871.6 to -$500.9.
E
Sell
3/11/2016Downgrade
Hemostemix Inc. (HEM.V) was downgraded to E+ from D on 3/11/2016 due to a major decline in the volatility index and total return index.
Hemostemix Inc. (HEM.V) was downgraded to E+ from D on 3/11/2016 due to a major decline in the volatility index and total return index.
D
Sell
2/25/2016Upgraded
Hemostemix Inc. (HEM.V) was upgraded to D from D- on 2/25/2016 due to an increase in the total return index, volatility index and valuation index.
Hemostemix Inc. (HEM.V) was upgraded to D from D- on 2/25/2016 due to an increase in the total return index, volatility index and valuation index.
D
Sell
1/12/2016Downgrade
Hemostemix Inc. (HEM.V) was downgraded to D- from D on 1/12/2016 due to a decline in the total return index and volatility index.
Hemostemix Inc. (HEM.V) was downgraded to D- from D on 1/12/2016 due to a decline in the total return index and volatility index.
D
Sell
12/28/2015Upgraded
Hemostemix Inc. (HEM.V) was upgraded to D from D- on 12/28/2015.
Hemostemix Inc. (HEM.V) was upgraded to D from D- on 12/28/2015.
D
Sell
8/3/2015Upgraded
Hemostemix Inc. (HEM.V) was upgraded to D- from E on 8/3/2015 due to an increase in the total return index and valuation index.
Hemostemix Inc. (HEM.V) was upgraded to D- from E on 8/3/2015 due to an increase in the total return index and valuation index.
E
Sell
7/6/2015Downgrade
Hemostemix Inc. (HEM.V) was downgraded to E from E+ on 7/6/2015 due to a noticeable decline in the volatility index, growth index and total return index.
Hemostemix Inc. (HEM.V) was downgraded to E from E+ on 7/6/2015 due to a noticeable decline in the volatility index, growth index and total return index.
E
Sell
6/18/2015Upgraded
Hemostemix Inc. (HEM.V) was upgraded to E+ from E on 6/18/2015 due to a large increase in the growth index, volatility index and valuation index.
Hemostemix Inc. (HEM.V) was upgraded to E+ from E on 6/18/2015 due to a large increase in the growth index, volatility index and valuation index.
E
Sell
5/1/2015Upgraded
Hemostemix Inc. (HEM.V) was upgraded to E from E- on 5/1/2015 due to an increase in the volatility index, solvency index and total return index. The quick ratio increased from 4.73 to 6.79.
Hemostemix Inc. (HEM.V) was upgraded to E from E- on 5/1/2015 due to an increase in the volatility index, solvency index and total return index. The quick ratio increased from 4.73 to 6.79.
E
Sell
4/21/2015Downgrade
Hemostemix Inc. (HEM.V) was downgraded to E- from E on 4/21/2015 due to a noticeable decline in the volatility index.
Hemostemix Inc. (HEM.V) was downgraded to E- from E on 4/21/2015 due to a noticeable decline in the volatility index.
E
Sell
2/24/2015None
Hemostemix Inc. (HEM.V) was downgraded to E from U on 02/24/2015.
Hemostemix Inc. (HEM.V) was downgraded to E from U on 02/24/2015.
